Abstract
BackgroundAchieving sustained clinical response to biologics is part of treat-to-target recommendations in psoriatic arthritis (PsA) and is aimed at optimising treatment goals.1ObjectivesTo evaluate patient (pt)-level secukinumab data and report the...
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have